CardioFocus announced that investigators completed the first series of treatments in a study of its OptiShot pulsed-field ...

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today ...

Pulse Biosciences (PLSE) announced a new publication in the Journal of Thoracic and Cardiovascular Surgery. This preclinical study demonstrates ...

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationtm (nano-PFA or nsPFAtm) technology, today announced a new publication in the Journal of ...

Catheter ablation for VT can reduce the need for ICD therapies and is an increasingly important adjunct to the treatment of these patients. Ventricular scars are a major source of substrate for ...

The global electrophysiology market is poised for significant growth, projected to expand from USD 4,350.7 billion in 2024 to USD 9,078.4 billion by 2034, at a robust CAGR of 7.6%. This remarkable ...

Adagio Medical Holdings, Inc. , a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that founder Olav Bergheim departed as Chief Executive ...

Usen’s appointment follows the departure of Olav Bergheim, the company’s founder, CEO and board chair, effective Dec. 13. The ...

Pediatr Crit Care Med. 2013;14(3):273-283.

ER-REBOA PLUS Catheter REBOA (occlusion catheter) Distal Intended for temporary occlusion of large vessels and blood pressure monitoring including patients requiring emergency control of hemorrhage ...

Which drugs or classes of drugs account for most cases of drug reaction with eosinophilia and systemic symptoms (DRESS)? Aromatic anticonvulsants confer the highest risk of associated DRESS ...

Cardiology is a medical specialty that is concerned with the structure and function of the heart and vasculature, and the diagnosis and treatment of patients with cardiovascular diseases ...